Lamivudine Tablet, Film Coated
Product Images NDC 60429-353

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Lamivudine (NDC 60429-353). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Golden State Medical Supply, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

60429 353 60lb Lamivudine 150 mg Tabs

This is a drug package containing 60 tablets of 150mg Lamivudine, an antiviral medication used to treat chronic hepatitis B and HIV/AIDS. Dosage information is available in the package insert. The package also includes storage instructions to be kept at 20°C to 25°C with permitted temperature excursions from 15°C to 30°C.*

FDA Label Image

60429 354 30lb Lamivudine 300mg Tabs

This is a description of a medication named Lamivudine. It comes in tablet form, contains 300mg of medication, and is supplied in a package containing 30 tablets. Dosage information is available inside the package. Storage requirements are listed as between 20°C and 25°C, with permitted excursions between 15°C to 30°C. The remaining text appears to be corrupted and unreadable.*

FDA Label Image

Chemical-structure (Chemical Structure)

FDA Label Image

Figure1 (Figure1)

This is a prescription dosing information for lamivudine, an antiretroviral medication commonly used to treat HIV and hepatitis B infections. It indicates that lamivudine can be taken in two different doses: 150 mg twice daily or 300 mg once daily. The numbers at the bottom of the text appear to be a graph measuring treatment time in weeks.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.